Diagnostic Testing Panel Discussion | 2022 Best of Breast Conference

Diagnostic Testing Panel Discussion | 2022 Best of Breast Conference

Patients with High Risk Features | 2023 Best of Breast ConferenceПодробнее

Patients with High Risk Features | 2023 Best of Breast Conference

Breast Cancer Patient Perspectives Panel Discussion | 2022 Best of Breast ConferenceПодробнее

Breast Cancer Patient Perspectives Panel Discussion | 2022 Best of Breast Conference

Breast Cancer Case-Based Panel Discussion | 2022 Midwest Women's Cancer ConferenceПодробнее

Breast Cancer Case-Based Panel Discussion | 2022 Midwest Women's Cancer Conference

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

Endocrine-disrupting Chemicals (EDCS) | ENDO 2022 Press ConferenceПодробнее

Endocrine-disrupting Chemicals (EDCS) | ENDO 2022 Press Conference

Panel Discussion | Dr B K SMRUTI | DIAGNOSTICS IN BREAST CANCER WHERE ARE WE IN 2022Подробнее

Panel Discussion | Dr B K SMRUTI | DIAGNOSTICS IN BREAST CANCER WHERE ARE WE IN 2022

HER2+ Breast Cancer Case Panel Discussion | 2022 Best of Breast ConferenceПодробнее

HER2+ Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference

Triple Negative Breast Cancer Case Panel Discussion | 2022 Best of Breast ConferenceПодробнее

Triple Negative Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference

ER+ Breast Cancer Case Panel Discussion | 2022 Best of Breast ConferenceПодробнее

ER+ Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference

High-Risk Patient Breast Cancer Case Panel Discussion | 2022 Best of Breast ConferenceПодробнее

High-Risk Patient Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference